VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FOLD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FOLDAmicus Therapeutics, Inc.
$14.49$4.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFOLDQuarterly Financials

Amicus Therapeutics, Inc. (FOLD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Amicus Therapeutics, Inc. (FOLD) quarterly income statement — complete revenue, gross profit & net income history

FOLD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue185.21M169.06M154.69M125.25M149.71M141.52M126.67M110.4M115.08M103.5M94.5M86.27M88.1M81.69M80.73M78.72M82.15M79.55M77.41M66.4M
Revenue Growth %23.72%19.46%22.12%13.45%30.09%36.73%34.04%27.97%30.63%26.7%17.06%9.6%7.23%2.7%4.29%18.54%16.41%17.95%24.15%9.71%
Cost of Goods Sold28.44M21.34M15.22M11.7M14.84M13.28M11.26M13.57M11.32M9.95M9.11M6.94M9.38M13.44M8.2M7.58M7.85M11.7M8.38M6.54M
COGS % of Revenue15.36%12.62%9.84%9.34%9.91%9.38%8.89%12.29%9.84%9.61%9.64%8.05%10.65%16.45%10.15%9.63%9.56%14.7%10.83%9.85%
Gross Profit156.77M147.72M139.47M113.55M134.87M128.24M115.41M96.84M103.76M93.56M85.39M79.33M78.71M68.25M72.53M71.13M74.3M67.85M69.03M59.86M
Gross Margin %84.64%87.38%90.16%90.66%90.09%90.62%91.11%87.71%90.16%90.39%90.36%91.95%89.35%83.55%89.85%90.37%90.44%85.3%89.17%90.15%
Gross Profit Growth %16.24%15.19%20.85%17.26%29.99%37.07%35.16%22.07%31.82%37.07%17.72%11.52%5.93%0.6%5.07%18.83%21.5%14.92%23.99%10.91%
Operating Expenses140.82M113.45M148.94M121.5M118.9M106.58M100.44M124.56M107.45M110.58M104.25M116.96M121.04M102.09M133.15M146.47M146.45M110.25M107.87M112.92M
OpEx % of Revenue76.03%67.11%96.29%97.01%79.42%75.31%79.29%112.82%93.37%106.84%110.31%135.58%137.4%124.98%164.93%186.08%178.26%138.6%139.34%170.05%
Selling, General & Admin117.08M90.04M84.54M91.83M86.67M75.11M73.58M88.03M70.24M65.65M65.42M73.96M54.27M47.27M53.38M58.12M57.6M46.11M42.28M46.73M
SG&A % of Revenue63.21%53.26%54.65%73.32%57.89%53.07%58.09%79.73%61.03%63.43%69.23%85.73%61.61%57.87%66.12%73.83%70.11%57.96%54.61%70.37%
Research & Development23.74M23.41M60.85M27.84M30.19M26.16M24.68M28.33M35.03M40.7M35.15M41.5M63.87M52.97M78.32M81.52M85.6M59.33M63M64.12M
R&D % of Revenue12.82%13.85%39.34%22.23%20.17%18.49%19.49%25.66%30.44%39.33%37.19%48.1%72.5%64.84%97.01%103.56%104.19%74.59%81.39%96.56%
Other Operating Expenses001000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income15.95M34.27M-9.47M-7.95M15.97M21.66M14.97M-27.72M-3.69M-17.02M-18.86M-37.64M-42.33M-33.84M-60.61M-75.34M-72.15M-42.4M-38.83M-53.05M
Operating Margin %8.61%20.27%-6.12%-6.35%10.67%15.3%11.82%-25.11%-3.21%-16.45%-19.96%-43.63%-48.05%-41.42%-75.08%-95.71%-87.82%-53.3%-50.16%-79.9%
Operating Income Growth %-0.16%58.22%-163.3%71.31%532.58%227.23%179.36%26.34%91.28%49.7%68.88%50.04%41.33%20.19%-56.08%-42%-11.28%19.64%24.37%32.03%
EBITDA17.84M36.14M-7.62M-6.12M18.01M23.83M17.15M-25.57M-1.51M-14.79M-16.65M-36.38M-41.02M-32.55M-59.28M-73.93M-70.63M-40.88M-37.27M-51.45M
EBITDA Margin %9.63%21.38%-4.93%-4.88%12.03%16.84%13.54%-23.16%-1.31%-14.29%-17.62%-42.17%-46.56%-39.85%-73.43%-93.92%-85.97%-51.39%-48.14%-77.48%
EBITDA Growth %-0.94%51.68%-144.45%76.08%1292.85%261.06%202.97%29.72%96.32%54.55%71.91%50.79%41.93%20.36%-59.07%-43.69%-13.39%18.67%24.42%32.56%
D&A (Non-Cash Add-back)1.9M1.87M1.85M1.84M2.04M2.17M2.18M2.15M2.18M2.23M2.21M1.26M1.31M1.29M1.33M1.41M1.52M1.52M1.57M1.6M
EBIT14.57M45.98M-7.62M-6.59M19.89M19.48M12.62M-31.15M-18.83M-11.72M-28.02M-41.38M-58.98M-19.64M-52.99M-73.3M-72.13M-42.31M-38.55M-56.09M
Net Interest Income-10.6M-10.88M-10.72M-10.64M-10.54M-11.61M-11.14M-10.9M-11.16M-11.52M-10.76M-9.64M-9.12M-9.06M-7.9M-8.01M-7.98M-8.06M-8.1M-7.83M
Interest Income833K829K843K812K1.42M1.08M1.37M1.54M1.67M1.47M1.74M2.2M1.97M563K356K133K186K108K50K165K
Interest Expense11.43M11.71M11.56M11.46M11.96M12.69M12.51M12.44M12.83M12.99M12.49M11.84M11.1M9.62M8.26M8.15M8.16M8.16M8.15M7.99M
Other Income/Expense-12.8M5K-9.71M-10.09M-8.04M-14.87M-14.86M-15.86M-27.97M-7.68M-21.66M-15.58M-27.75M4.58M-633K-6.11M-8.15M-8.08M-7.87M-11.03M
Pretax Income3.14M34.27M-19.18M-18.05M7.93M6.79M108K-43.58M-31.66M-24.7M-40.52M-53.22M-70.08M-29.26M-61.25M-81.45M-80.3M-50.48M-46.7M-64.08M
Pretax Margin %1.7%20.27%-12.4%-14.41%5.3%4.79%0.09%-39.48%-27.51%-23.87%-42.87%-61.69%-79.55%-35.82%-75.86%-103.48%-97.74%-63.46%-60.33%-96.51%
Income Tax1.45M16.97M5.24M3.64M-6.8M13.51M15.8M4.84M2.18M-3.13M2.71M-287K-14.21M4.02M911K3.81M2.98M-182K4.53M1.58M
Effective Tax Rate %46.23%49.51%-27.31%-20.18%-85.77%199.17%14634.26%-11.1%-6.9%12.66%-6.7%0.54%20.28%-13.75%-1.49%-4.68%-3.71%0.36%-9.69%-2.47%
Net Income1.69M17.31M-24.42M-21.69M14.74M-6.73M-15.7M-48.42M-33.84M-21.58M-43.23M-52.93M-55.87M-33.29M-62.16M-85.26M-83.28M-50.29M-51.23M-65.66M
Net Margin %0.91%10.24%-15.79%-17.31%9.85%-4.75%-12.39%-43.86%-29.41%-20.85%-45.75%-61.36%-63.41%-40.75%-76.99%-108.31%-101.37%-63.23%-66.17%-98.89%
Net Income Growth %-88.53%357.19%-55.57%55.21%143.55%68.81%63.69%8.53%39.42%35.18%30.45%37.92%32.92%33.82%-21.34%-29.84%-16.63%21.43%2.41%26.18%
Net Income (Continuing)1.69M17.31M-24.42M-21.69M14.74M-6.73M-15.7M-48.42M-33.84M-21.58M-43.23M-52.93M-55.87M-33.29M-62.16M-85.26M-83.28M-50.29M-51.23M-65.66M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.010.06-0.08-0.070.05-0.02-0.05-0.16-0.12-0.07-0.15-0.18-0.20-0.12-0.21-0.30-0.30-0.19-0.19-0.25
EPS Growth %-89.05%379%-60%56.25%142.76%71.43%66.67%11.11%41.97%41.67%28.57%40%33.46%36.84%-10.53%-20%-9.58%24%5%28.57%
EPS (Basic)0.010.06-0.08-0.070.05-0.02-0.05-0.16-0.12-0.07-0.15-0.18-0.20-0.12-0.21-0.30-0.30-0.19-0.19-0.25
Diluted Shares Outstanding314.36M310.43M308.25M307.69M299.04M304.69M303.77M302.9M293.59M295.76M292.8M291.34M281.11M289.22M291.97M288.48M278.91M267.46M266.4M264.37M
Basic Shares Outstanding309.03M308.47M308.25M307.69M299.04M304.69M303.77M302.9M293.59M295.76M292.8M291.34M281.11M289.22M291.97M288.48M278.91M267.46M266.4M264.37M
Dividend Payout Ratio--------------------